Clinical trial protocol for TRANSFORM‐UK: A therapeutic open‐label study of tocilizumab in the treatment of pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Clinical trial protocol for TRANSFORM‐UK: A therapeutic open‐label study of tocilizumab in the treatment of pulmonary arterial hypertension

Published:2017-11 Issue:1 Volume:8 Page:1-8
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Hernández‐Sánchez Jules¹,Harlow Louise²,Church Colin³,Gaine Sean⁴,Knightbridge Emily²,Bunclark Kate²,Gor Dee⁵,Bedding Alun⁵,Morrell Nicholas⁶,Corris Paul⁷,Toshner Mark²⁶^ORCID

Affiliation:

1. Papworth Trials Unit CollaborationPapworth HospitalCambridgeUK

2. Pulmonary Vascular Disease UnitPapworth HospitalCambridgeUK

3. Golden Jubilee HospitalGlasgowUK

4. Mater MisericordiaDublinIreland

5. Roche PharmaceuticalsWelwyn Garden CityUK

6. University of CambridgeCambridgeUK

7. University of NewcastleNewcastleUK

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1177/2045893217735820

Reference28 articles.

1. A meta‐analysis of randomized controlled trials in pulmonary arterial hypertension;Galie N;Eur Heart J,2009

2. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland;Ling Y;Am J Respir Crit Care Med,2012

3. Connective tissue disease‐associated pulmonary arterial hypertension in the modern treatment era;Condliffe R;Am J Respir Crit Care Med,2009

4. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial;Abraham WT;Lancet,2011

5. Comparative effectiveness and safety of drug therapy for pulmonary arterial hypertension: a systematic review and meta‐analysis;Coeytaux RR;Chest,2014

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare immune-related adverse effect of pembrolizumab: pulmonary hypertension;Journal of Chemotherapy;2024-05-08

2. Tocilizumab Failed to Reduce Mortality in Severe COVID-19 Patients: Results from a Randomized Controlled Clinical Trial;Iranian Journal of Allergy, Asthma and Immunology;2024-02-20

3. Tetralogy of Fallot Across the Lifespan: A Focus on the Right Ventricle;CJC Pediatric and Congenital Heart Disease;2023-12

4. Targeting IL-11 system as a treatment of pulmonary arterial hypertension;Pharmacological Research;2023-11

5. Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension;Expert Opinion on Investigational Drugs;2023-10-30